se ha leído el artículo
array:25 [ "pii" => "S0001731022008833" "issn" => "00017310" "doi" => "10.1016/j.ad.2022.10.029" "estado" => "S300" "fechaPublicacion" => "2022-12-01" "aid" => "3251" "copyright" => "AEDV" "copyrightAnyo" => "2021" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2022;113 Supl 1:TS8-TS9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S0001731021004105" "issn" => "00017310" "doi" => "10.1016/j.ad.2021.07.010" "estado" => "S300" "fechaPublicacion" => "2022-12-01" "aid" => "2801" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2022;113 Supl 1:S10-S12" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta científico-clínica</span>" "titulo" => "Incontinencia pigmenti: ¿es una entidad más grave en los varones? Reporte de 2 casos" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "S10" "paginaFinal" => "S12" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Is Incontinentia Pigmenti More Serious in Males? A Report of 2 Cases" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figura 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 369 "Ancho" => 1305 "Tamanyo" => 75532 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">A y B) Lesiones verrucosas (estadio 2) siguiendo las líneas de Blaschko. C) Epidermis: espongiosis con formación de vesículas espongióticas intradérmicas y exocitosis de numerosos eosinófilos. Células disqueratósicas con citoplasma hialino. Dermis con edema e infiltrado inflamatorio superficial mononuclear con eosinófilos y melanófagos.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "V. Vezzaro, M. de María, L. Lucas, A. Acosta" "autores" => array:4 [ 0 => array:2 [ "nombre" => "V." "apellidos" => "Vezzaro" ] 1 => array:2 [ "nombre" => "M." "apellidos" => "de María" ] 2 => array:2 [ "nombre" => "L." "apellidos" => "Lucas" ] 3 => array:2 [ "nombre" => "A." "apellidos" => "Acosta" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021004105?idApp=UINPBA000044" "url" => "/00017310/00000113000000S1/v1_202212200523/S0001731021004105/v1_202212200523/es/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S0001731021004518" "issn" => "00017310" "doi" => "10.1016/j.ad.2021.08.009" "estado" => "S300" "fechaPublicacion" => "2022-12-01" "aid" => "2834" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2022;113 Supl 1:S8-S9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENTÍFICO-CLÍNICA</span>" "titulo" => "Dermatitis alérgica de contacto por minoxidil en paciente con alopecia areata" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "S8" "paginaFinal" => "S9" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Allergic Contact Dermatitis Due to Minoxidil in a Patient with Alopecia Areata" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1175 "Ancho" => 1255 "Tamanyo" => 209121 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A y B. Erupción eccematosa en el cuello. C. Minoxidil al 1 y 5% en DMSO preparado por nuestro Servicio de Farmacia Hospitalaria. D. Prueba de parche negativa en el día 2 de minoxidil al 1 y 5% en DMSO. E. Prueba de parche positiva en el día 4 de minoxidil al 1 y 5% en DMSO.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F.J. Navarro-Triviño, M.D. Pegalajar-García, A. Gil-Villalba, R. Ruiz-Villaverde" "autores" => array:4 [ 0 => array:2 [ "nombre" => "F.J." "apellidos" => "Navarro-Triviño" ] 1 => array:2 [ "nombre" => "M.D." "apellidos" => "Pegalajar-García" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Gil-Villalba" ] 3 => array:2 [ "nombre" => "R." "apellidos" => "Ruiz-Villaverde" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021004518?idApp=UINPBA000044" "url" => "/00017310/00000113000000S1/v1_202212200523/S0001731021004518/v1_202212200523/es/main.assets" ] "asociados" => array:1 [ 0 => array:19 [ "pii" => "S0001731021004518" "issn" => "00017310" "doi" => "10.1016/j.ad.2021.08.009" "estado" => "S300" "fechaPublicacion" => "2022-12-01" "aid" => "2834" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2022;113 Supl 1:S8-S9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENTÍFICO-CLÍNICA</span>" "titulo" => "Dermatitis alérgica de contacto por minoxidil en paciente con alopecia areata" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "S8" "paginaFinal" => "S9" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Allergic Contact Dermatitis Due to Minoxidil in a Patient with Alopecia Areata" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1175 "Ancho" => 1255 "Tamanyo" => 209121 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A y B. Erupción eccematosa en el cuello. C. Minoxidil al 1 y 5% en DMSO preparado por nuestro Servicio de Farmacia Hospitalaria. D. Prueba de parche negativa en el día 2 de minoxidil al 1 y 5% en DMSO. E. Prueba de parche positiva en el día 4 de minoxidil al 1 y 5% en DMSO.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F.J. Navarro-Triviño, M.D. Pegalajar-García, A. Gil-Villalba, R. Ruiz-Villaverde" "autores" => array:4 [ 0 => array:2 [ "nombre" => "F.J." "apellidos" => "Navarro-Triviño" ] 1 => array:2 [ "nombre" => "M.D." "apellidos" => "Pegalajar-García" ] 2 => array:2 [ "nombre" => "A." "apellidos" => "Gil-Villalba" ] 3 => array:2 [ "nombre" => "R." "apellidos" => "Ruiz-Villaverde" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731021004518?idApp=UINPBA000044" "url" => "/00017310/00000113000000S1/v1_202212200523/S0001731021004518/v1_202212200523/es/main.assets" ] ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>" "titulo" => " Allergic Contact Dermatitis Due to Minoxidil in a Patient With Alopecia Areata" "tieneTextoCompleto" => true "saludo" => "To the Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "TS8" "paginaFinal" => "TS9" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "F.J. Navarro-Triviño, G.-V.A. Pegalajar-García, R. Ruiz-Villaverde" "autores" => array:3 [ 0 => array:2 [ "nombre" => "F.J." "apellidos" => "Navarro-Triviño" ] 1 => array:2 [ "nombre" => "G.-V.A." "apellidos" => "Pegalajar-García" ] 2 => array:4 [ "nombre" => "R." "apellidos" => "Ruiz-Villaverde" "email" => array:1 [ 0 => "ismenios@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Dermatología, Hospital Universitario San Cecilio, Inst Invest Biosanitaria IBS Granada, Granada, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Dermatitis alérgica de contacto por minoxidil en paciente con alopecia areata" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1176 "Ancho" => 1256 "Tamanyo" => 208172 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A and B, Eczematous rash on the neck. C, Minoxidil 1% and 5% in dimethyl sulfoxide (DMSO) prepared by the hospital pharmacy. D, Negative patch test to minoxidil 1% and 5% in DMSO on day 2. E, Positive patch test to minoxidil 1% and 5% in DMSO on day 4.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Topical 2,6-diamino-4-piperidinopyrimidine 1-oxide (minoxidil) is probably the most widely used treatment for different types of alopecia. Although the topical solution is usually well tolerated, continued application can sometimes result in itching and irritant contact dermatitis.</p><p id="par0010" class="elsevierStylePara elsevierViewall">A 38-year-old man with no personal or family history of interest was referred to our cutaneous immunoallergy unit for evaluation of an eczematous neck rash that had developed over the previous 2 months.</p><p id="par0015" class="elsevierStylePara elsevierViewall">He had been using topical minoxidil (Regaxidil) to treat alopecia areata for the previous 3 months. He mentioned an episode of alopecia areata characterized by multiple patches in childhood (at the age of 6 years) that had been treated with topical minoxidil at an unknown concentration. The treatment led to complete resolution after 6 months, and until now he had not experienced any other episodes.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Physical examination revealed erythematous, edematous papules and patches in the occipital region of the neck (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>A and B). The patient was patch tested with the European Baseline Series (Chemotechnique Diagnostics), 30% aqueous propylene glycol, and minoxidil 1% and 5% in dimethylsulfoxide (DMSO) (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>C). The results were interpreted using the criteria of the International Contact Dermatitis Research Group. Readings were performed on days 2 and 4. The reaction to minoxidil 1% and 5% in DMSO was negative on day 2 (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>D) and positive (++/+++) on day 4 (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>E). Patch tests with minoxidil 1% and 5% in DMSO were negative in 12 controls.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0025" class="elsevierStylePara elsevierViewall">The patient was diagnosed with allergic contact dermatitis due to minoxidil. The product was discontinued and the lesions disappeared completely within a week. No signs of hair regrowth were observed, despite the inflammatory reaction to contact dermatitis from minoxidil.</p><p id="par0030" class="elsevierStylePara elsevierViewall">Few cases of allergic contact dermatitis due to minoxidil have been reported.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">1</span></a> Other contact reactions related to the topical application of this product include pustular allergic contact dermatitis,<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">2</span></a> occupational allergic contact dermatitis, and pigmented contact dermatitis.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">3</span></a> A case of persistent allergic patch test reactions to minoxidil manifesting as cutaneous lymphoid hyperplasia has also been reported.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">4</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">Choice of vehicle is important for patch testing. Direct testing may generate doubts, as topical minoxidil solution contains propylene glycol. That is why we chose DMSO as a vehicle, as it favors penetration of the active ingredients and is valid for both hydrophilic and lipophilic substances.</p><p id="par0040" class="elsevierStylePara elsevierViewall">The recent introduction of oral minoxidil has revolutionized the treatment of certain forms of alopecia (androgenetic alopecia).<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">5</span></a> Identifying patients sensitized to topical minoxidil could be important, as certain patients with alopecia may require oral minoxidil to control hair loss. Although oral minoxidil can probably be safely used, the possibility of systemic contact dermatitis cannot be fully ruled out, despite early reports suggesting it is unlikely.<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">6,7</span></a></p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicts of Interest</span><p id="par0045" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflicts of Interest" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1176 "Ancho" => 1256 "Tamanyo" => 208172 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A and B, Eczematous rash on the neck. C, Minoxidil 1% and 5% in dimethyl sulfoxide (DMSO) prepared by the hospital pharmacy. D, Negative patch test to minoxidil 1% and 5% in DMSO on day 2. E, Positive patch test to minoxidil 1% and 5% in DMSO on day 4.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:7 [ 0 => array:3 [ "identificador" => "bib0040" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Allergic contact dermatitis from minoxidil" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "H. Ebner" 1 => "E. Müller" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-0536.1995.tb00798.x" "Revista" => array:6 [ "tituloSerie" => "Contact Dermatitis" "fecha" => "1995" "volumen" => "32" "paginaInicial" => "316" "paginaFinal" => "317" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7634798" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0045" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pustular allergic contact dermatitis from topical minoxidil 5%" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Rodríguez-Martín" 1 => "M. Sáez-Rodríguez" 2 => "A. Carnerero-Rodríguez" 3 => "R. Cabrera de Paz" 4 => "M. Sidro-Sarto" 5 => "N. Pérez-Robayna" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1468-3083.2006.01996.x" "Revista" => array:6 [ "tituloSerie" => "J Eur Acad Dermatol Venereol" "fecha" => "2007" "volumen" => "21" "paginaInicial" => "701" "paginaFinal" => "702" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17447999" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0050" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pigmented contact dermatitis from topical minoxidil 5%" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Trattner" 1 => "M. David" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1034/j.1600-0536.2002.460416.x" "Revista" => array:5 [ "tituloSerie" => "Contact Dermatitis" "fecha" => "2002" "volumen" => "46" "paginaInicial" => "246" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12081710" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0055" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Persisting allergic patch test reaction to minoxidil manifested as cutaneous lymphoid hyperplasia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "S. García-Rodiño" 1 => "M. Espasandín-Arias" 2 => "J.M. Suárez-Peñaranda" 3 => "M.T. Rodríguez-Granados" 4 => "H. Vázquez-Veiga" 5 => "V. Fernández-Redondo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/cod.12371" "Revista" => array:6 [ "tituloSerie" => "Contact Dermatitis" "fecha" => "2015" "volumen" => "72" "paginaInicial" => "413" "paginaFinal" => "416" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25801327" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0060" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Beach RA, McDonald KA, Barrett BM. Tolerated, effective, successful: low dose oral minoxidil for treating alopecia, a 3-year North American retrospective case series. J Am Acad Dermatol. 2020;S0190-9622:32844-9." ] ] ] 5 => array:3 [ "identificador" => "bib0065" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Therianou A, Vincenzi C, Tosti A. How safe is prescribing oral minoxidil in patients allergic to topical minoxidil? J Am Acad Dermatol. 2020;S0190-9622:30567-3." ] ] ] 6 => array:3 [ "identificador" => "bib0070" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Contact dermatitis to minoxidil" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A. Tosti" 1 => "F. Bardazzi" 2 => "M.P. de Padova" 3 => "G.M. Caponeri" 4 => "M. Melino" 5 => "S. Veronesi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-0536.1985.tb02568.x" "Revista" => array:6 [ "tituloSerie" => "Contact Dermatitis" "fecha" => "1985" "volumen" => "13" "paginaInicial" => "275" "paginaFinal" => "276" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/4085233" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/00017310/00000113000000S1/v1_202212200523/S0001731022008833/v1_202212200523/en/main.assets" "Apartado" => array:4 [ "identificador" => "6160" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Cartas científico-clínicas" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/00017310/00000113000000S1/v1_202212200523/S0001731022008833/v1_202212200523/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731022008833?idApp=UINPBA000044" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 21 | 12 | 33 |
2024 Octubre | 156 | 83 | 239 |
2024 Septiembre | 182 | 56 | 238 |
2024 Agosto | 222 | 104 | 326 |
2024 Julio | 150 | 71 | 221 |
2024 Junio | 130 | 66 | 196 |
2024 Mayo | 139 | 76 | 215 |
2024 Abril | 101 | 70 | 171 |
2024 Marzo | 87 | 56 | 143 |
2024 Febrero | 78 | 64 | 142 |
2024 Enero | 98 | 61 | 159 |
2023 Diciembre | 160 | 51 | 211 |
2023 Noviembre | 194 | 86 | 280 |
2023 Octubre | 223 | 76 | 299 |
2023 Septiembre | 164 | 43 | 207 |
2023 Agosto | 194 | 45 | 239 |
2023 Julio | 189 | 71 | 260 |
2023 Junio | 103 | 35 | 138 |
2023 Mayo | 176 | 34 | 210 |
2023 Abril | 87 | 30 | 117 |
2023 Marzo | 117 | 29 | 146 |
2023 Febrero | 114 | 36 | 150 |
2023 Enero | 120 | 41 | 161 |
2022 Diciembre | 130 | 54 | 184 |
2022 Noviembre | 96 | 45 | 141 |
2022 Octubre | 74 | 71 | 145 |